Contact Us
|
Chinese
友情链接:
澳门百家乐
真人百家乐
真人百家乐网
百家乐官网
Home
|
News
Company News
|
Industry News
|
Picture News
|
About CSC
|
Milestone
|
Advantage
|
IDL ability
Description
|
Case
|
IDL Sample
|
Product
API Catalogue
|
API Picture
|
Excipient Catalogue
|
Excipient Picture
|
Transportation
Ability
|
Pictures
|
Contact Us
|
Chinese
网上百家乐
网页百家乐
澳门百家乐
News
百家乐代理
真人百家乐网
真人百家乐官网
真人百家乐
Company News
Industry News
Picture News
Company News
百家乐代理
真人百家乐
澳门百家乐
网页百家乐
CSC in CPHI Delhi 2019
2019-11-29
CSC attended CPHI Delhi 2019
[More]
CSC is going to attend CPHI 2019 Delhi (3.D08)
2019-09-30
[More]
CSC's Proposals to Drug Laws
2019-08-19
CSC's many proposals were adopted by NMPA and been put into the revised Drug Law.
[More]
CSC in CPHI China 2019
2019-06-28
CSC attended CPHI China 2019 in Shanghai.
[More]
CSC in CPHI Delhi 2018
2019-02-15
CSC in CPHI Delhi 2018
[More]
Conference for CFDA regulatory affairs&CFDI audit rules for import drugs
2019-01-08
Conference for CFDA regulatory affairs&CFDI audit rules for import drugs
[More]
CSC participate the INDIA-CHINA PHARMACEUTICAL CONFERENCE & BUSINESS MEET
2018-08-24
[More]
Congratulations! CSC got 16 imported APIs' market approval from CFDA
2018-08-01
[More]
CSC in CPHI CHINA 2018
2018-07-09
[More]
E1K20, CSC will participate CPHI 2018
2018-04-16
[More]
CSC will participate in CPHI 2017 Mumbai
2017-09-29
[More]
CSC in 2017 CPhI China
2017-06-26
[More]
Total: 28 prev 1
2
3
Next
Contact Us
Copyright
© 2013 China Chinopharma Ltd. All rights reserved.
真人百家乐网
百家乐官网注册
真人百家乐官网
真人百家乐